Its payday for investors in Regis Healthcare Ltd (ASX: REG) who will receive their 8.12 cents per share (cps) dividend today – so where should you consider investing this cash?
Regis Healthcare Ltd (ASX: REG)
The billion-dollar Aussie healthcare company has seen its share price soar 24.5% in 2019 and yet is still yielding a more-than-handy 4.92%.
The company’s share price growth has been fuelled by solid half-year results and a one-off Federal Government funding increase of $320 million for residential aged care.
While it’s been generally good news for investors in Regis so far this year, the ongoing Royal Commission into Aged Care presents a significant headwind for growth and the capex-intensive nature of the industry would make me wary of reinvesting my dividends in Regis.
Appen Limited (ASX: APX)
Appen has been yet another success story from the Aussie tech industry as IPO investors have seen the share price rise a phenomenal 4,610% from $0.50 per share in the IPO to $23.55 at yesterday’s close.
Appen’s share price has been rocketing higher in 2019 and is up 84% since the start of the year on the back of continued earnings guidance upgrades and outperformance.
I think the stock still has a lot of growth left in it despite its lofty price-earnings multiple, given tailwinds for technology and the expansion of artificial intelligence capabilities around the world.
AGL Energy Ltd (ASX: AGL)
AGL, alongside its fellow oil and gas peers, has benefitted from a domestic gas supply shortage and global oil prices reaching a 5-month high yesterday.
Despite an ongoing dispute with the Federal government over its decision to close its Liddell power plant, AGL could be in a strong position to benefit from a potential change of government in May 2019.
With Labor touting a more renewables-centric energy policy, AGL, as the largest energy company in Australia, is in the box seat to capitalise from higher capex and potential subsidies in the sector.
For those who want a more high-risk, high-return play in their portfolio, this buy-rated stock in a booming industry could be in the buy basket.
A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
And make no mistake – it is coming. To the tune of an estimated $US22 billion.
Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.
Here's the best part: we think there's one ASX stock that's uniquely positioned to profit immensely from this explosive new industry... taking savvy investors along for what could be one heck of a ride.
AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.
Motley Fool contributor Lachlan Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.